Valutazione Clinica E in Vitro Degli Effetti Dell'Alfa-Bloccante Nicergolina Sul Collo Vescicale

Arcari G. , Dorigotti L. , Fregnan G. B. , Glasser A. H. : Vasodilating and alpha-receptor blocking activity of a new ergoline derivactive. Brit. J. Pharmacol., 34; 700 (1960).

Boismare F. , Lorenzo J. : Study of protection afforded by Nicergoline against the effect of cerebral ischemia in the cat. Arzneim Forsch., 25; 410 (1975).

Boreham P. F. , Baithwaite P. , Milewsky P. , Pearson H. : Alpha-adrenergic blockers in prostatism. Brit. J. Surg., 64; 756 (1977).

Caine M. , Pfau A. , Perlberg S. : The use of alpha-adrenergic blockers in benign prostatic obstruction. Brit. J. Urol., 48; 255 (1976).

Caine M. , Perlberg S. , Meretyk S. : A placebo-controlled double blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Brit. J. Urol., 50; 551 (1978).

Caine M. , Raz S. , Zeigler M. : Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Brit. J. Urol., 47; 193 (1975).

Castro J. E. , Griffiths H. J. L. , Edwards D. E. : A double-blind controlled clinical trial of spironolactone for benign prostatic hypertrophy. Brit. J. Surg., 58; 485 (1971).

Farrar D. J. , Prior J. S. : The effect of bromocriptine in patients with benign prostatic hypertrophy. Brit. J. Urol., 48; 73 (1976).

Geller J. , Nelson C. G. , Albert J. D. , Pratt C. : Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy. Urology, 14; 467 (1979).

Grasso M. , Ronchi F. , Lania C. , Di Girolamo V. , Hadjigeorgiou D. , Annoni F. , Mantovani G. , Margonato A. : « In vitro » effect of nicergoline on the contractibility of human bladder neck. Farmaco, ed. prat., 12; 408 (1982).

Kaufman J. J. , Goodwin W. E. : Hormonal management of the benign obstructing prostate: use of combined androgen-estrogen therapy. J. Urol., 81; 165 (1959).

Koch G. : The use of non parametric methods in the statistical analysis of the two period change-over design. Biometrics, 28; 577 (1972).

Ronchi F. , Margonato A. , Ceccardi R. , Rigatti P. , Rossini B. M. : Symptomatic treatment of benign prostatic. obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation. Urol. Res., 10; 131 (1982).

Trimarchi F. , Gelmi C. , Marangoni R. : The alpha-adrenolytic action of nicergoline studied by pupillography: effect on phenylephrine-induced mydriasis. IRCS Med. Sci. (Research on: clinical pharmacology and therapeutics; eye), 2; 1640 (1974).

Triulzi E. , Devizzi S. , Margonato A. : Use of nicergoline in acute myocardial infarction with diastolic hypertension. II Farmaco, ed. prat., 36; 449 (1981).

Wallenstein S. : The analysis of the two period repeated measurements crossover design with application to clinical trials. Biometrics, 33; 261 (1977).